Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 류동열 | * |
dc.date.accessioned | 2016-08-29T12:08:54Z | - |
dc.date.available | 2016-08-29T12:08:54Z | - |
dc.date.issued | 2015 | * |
dc.identifier.issn | 0025-7974 | * |
dc.identifier.other | OAK-14651 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/230467 | - |
dc.description.abstract | Vitamin D deficiency is frequently found in patients with renal transplants (RTxs). Because vitamin D plays indispensable roles in the immune system, there may be an association between vitamin D deficiency and infection in these patients, but this has not been fully elucidated. Therefore, this study investigated the impact of pre-RTx vitamin D deficiency on urinary tract infection (UTI) development after RTx. We measured 25-hydroxyvitamin D3 (25(OH)D3) levels in 410 patients 2 weeks before they underwent RTx. Vitamin D deficiency was defined as 25(OH)D3 <10ng/mL. The primary outcome was UTI occurrence after RTx. Cox proportional hazard analysis determined whether vitamin D deficiency was independently associated with UTI. The mean 25(OH)D3 level was 12.8±6.9ng/mL, and 171 patients (41.7%) were vitamin D deficient. During a median follow-up duration of 7.3 years, the UTI incidence was significantly higher in vitamin D-deficient patients (52 patients, 30.4%) compared with vitamin D-nondeficient patients (40 patients, 16.7%) (P=0.001). Moreover, multivariate Cox proportional hazard analysis showed that vitamin D deficiency was an independent predictor of UTI after RTx (hazard ratio 1.81, 95% confidence interval 1.11-2.97, P=0.02). Vitamin D deficiency was an independent risk factor for UTI after RTx; hence, determining 25(OH)D3 levels might help to predict infectious complications after RTx. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. | * |
dc.language | English | * |
dc.publisher | Lippincott Williams and Wilkins | * |
dc.title | Vitamin D deficiency is an independent risk factor for urinary tract infections after renal transplants | * |
dc.type | Article | * |
dc.relation.issue | 9 | * |
dc.relation.volume | 94 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | e594 | * |
dc.relation.journaltitle | Medicine (United States) | * |
dc.identifier.doi | 10.1097/MD.0000000000000594 | * |
dc.identifier.wosid | WOS:000350756800015 | * |
dc.identifier.scopusid | 2-s2.0-84926334222 | * |
dc.author.google | Kwon Y.E. | * |
dc.author.google | Kim H. | * |
dc.author.google | Oh H.J. | * |
dc.author.google | Park J.T. | * |
dc.author.google | Han S.H. | * |
dc.author.google | Ryu D.-R. | * |
dc.author.google | Yoo T.-H. | * |
dc.author.google | Kang S.-W. | * |
dc.contributor.scopusid | 류동열(7103144218;56997547400;56669926200) | * |
dc.date.modifydate | 20240123102517 | * |